Literature DB >> 12611434

Myotonic dystrophy: discussion of molecular basis.

Lubov T Timchenko1, Steve J Tapscott, Thomas A Cooper, Darren G Monckton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12611434     DOI： 10.1007/978-1-4615-0117-6_2

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  4 in total

Review 1.  Structures of trinucleotide repeats in human transcripts and their functional implications.

Authors:  Anna Jasinska; Gracjan Michlewski; Mateusz de Mezer; Krzysztof Sobczak; Piotr Kozlowski; Marek Napierala; Wlodzimierz J Krzyzosiak
Journal:  Nucleic Acids Res       Date:  2003-10-01       Impact factor: 16.971

2.  Muscleblind-like 2: circadian expression in the mammalian pineal gland is controlled by an adrenergic-cAMP mechanism.

Authors:  Jong-So Kim; Steven L Coon; Joan L Weller; Seth Blackshaw; Martin F Rath; Morten Møller; David C Klein
Journal:  J Neurochem       Date:  2009-05-19       Impact factor: 5.372

3.  Pur alpha binds to rCGG repeats and modulates repeat-mediated neurodegeneration in a Drosophila model of fragile X tremor/ataxia syndrome.

Authors:  Peng Jin; Ranhui Duan; Abrar Qurashi; Yunlong Qin; Donghua Tian; Tracie C Rosser; Huijie Liu; Yue Feng; Stephen T Warren
Journal:  Neuron       Date:  2007-08-16       Impact factor: 17.173

4.  Myotonic dystrophy type 2: the 2020 update.

Authors:  Giovanni Meola
Journal:  Acta Myol       Date:  2020-12-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.